- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07449533
Smartphone Use in Healthcare Settings Among Nurses
Smartphone Use in Healthcare Settings: Nurses' Messages for Instant Action to Promote Patient Safety; A Cross-sectional Survey With Qualitative Open-ended Questions
Study Overview
Status
Intervention / Treatment
Detailed Description
This study employs a prospective observational design to investigate the integration of smartphone technology in nursing workflows and its direct implications for patient safety. As healthcare environments become increasingly fast-paced, the reliance on instant messaging (e.g., WhatsApp, specialized hospital apps) for clinical communication has grown.
The research focuses on several key dimensions:
Communication Efficiency: Assessing how instant messages facilitate rapid clinical decision-making and "instant action" compared to traditional communication methods.
- An online self-administered questionnaire will be used for the quantitative part; it will be shared with participants through their personal WhatsApp number after meeting them and getting their approval to participate in the study.
- Semi-structured interviews will be used to collect data for the qualitative part; interviews will be conducted in the Arabic language, either face-to-face or online through the MS Teams platform (synchronous/asynchronous) mode for easy contact with participants
Patient Safety Outcomes: Monitoring the reporting of critical lab values, medication clarifications, and urgent patient status changes through digital messages.
Workflow Integration: Identifying how nurses prioritize urgent clinical messages amidst their daily responsibilities.
Data collection involves a mixed-methods approach, including the analysis of communication patterns and clinical outcome indicators. The study aims to provide evidence-based insights into how smartphone use can be standardized to minimize risks and maximize the speed of life-saving interventions in hospital settings.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Alexandria, Egypt, 21511
- Faculty of Nursing, Alexandria University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
Device Usage: Must actively use a personal communication device (smartphone or tablet) during working hours for either personal or professional purposes.
Work Setting: Must be assigned to in-patient care units where direct patient monitoring and interaction occur.
Exclusion Criteria:
- Nurses on leave or those who declined to participate
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Participating Nurses
This arm includes staff nurses to assess their patterns of personal communication device use including frequency, duration, and types of applications while simultaneously evaluating the subsequent impact of these devices on in-patient care.
Through a convergent parallel mixed-methods approach, the study examines how these usage patterns influence clinical workflows, nurses' responsiveness, and overall patient safety, focusing on identifying both the professional benefits and potential risks associated with the use of personal devices in clinical settings.
|
Participants will complete surveys and participate in interviews to assess their patterns of using personal communication devices during work hours. The intervention focuses on identifying frequency, duration, and clinical vs. personal use, as well as evaluating the perceived and actual impact of these behaviors on in-patient care quality and patient safety incidents. 368 nurses from Govermental Hospitals across medical-surgical, critical care, emergency, operating theater, outpatient, home care, and psychiatric settings |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Patterns of Personal Communication Device usage.
Time Frame: October 2025 and February 2026
|
Evaluation of how frequently and for what duration nurses use their personal devices for both professional and personal purposes during shift hours, measured via a structured survey.
|
October 2025 and February 2026
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Impact of Personal Communication Device Use on In-patient Care Indicators
Time Frame: October 2025 and February 2026
|
Assessment of the correlation between device usage patterns and clinical care quality, such as nurses' responsiveness to patient needs and the frequency of reported near-misses or clinical errors related to distraction.
|
October 2025 and February 2026
|
|
Nurses' Perceptions and Reported Clinical Incidents.
Time Frame: October 2025 and February 2026
|
Qualitative analysis of themes derived from nurses' descriptions of specific incidents and their subjective views on how smartphone messaging facilitates "instant action" or impacts patient safety.
|
October 2025 and February 2026
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- AU-20-10-432
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Study Data/Documents
-
Study Protocol
Information comments: Available upon request from the Principal Investigator for legitimate research purposes
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Mobile Applications
-
University Grenoble AlpsCompletedMobile Applications | Mobile HealthFrance
-
Universitaire Ziekenhuizen KU LeuvenEnrolling by invitationMobile ApplicationsBelgium
-
National University of MalaysiaCompletedMobile ApplicationsMalaysia
-
University College DublinCompletedExercise | Mobile ApplicationsIreland
-
Vicente Lorenzo-Zúñiga GarcíaCompletedMobile Applications | Cathartics
-
Ondokuz Mayıs UniversityNot yet recruitingMobile Applications | Organ Transplantation | NursingTurkey (Türkiye)
-
Universitair Ziekenhuis BrusselUnknown
-
Istanbul University - CerrahpasaCompletedCancer | Mobile Applications | Chemotherapeutic ToxicityTurkey
-
Washington University School of MedicineMallinckrodtCompletedHealthy Volunteers | Mobile Applications | Feasibility StudyUnited States
-
University of TorontoUnknownMobile Applications | Diet, Healthy | Behavior, HealthCanada
Clinical Trials on Assessment of Personal Communication Device Usage Patterns.
-
University of Southern CaliforniaNational Cancer Institute (NCI)RecruitingMalignant Solid Neoplasm | Hodgkin Lymphoma | Anatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage IA Breast Cancer AJCC v8 | Anatomic Stage IB Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIA Breast Cancer AJCC v8 | Anatomic Stage IIB Breast Cancer AJCC v8 | Anatomic... and other conditionsUnited States
-
Thomas Jefferson UniversityWithdrawnMyelodysplastic SyndromesUnited States
-
OHSU Knight Cancer InstituteNational Cancer Institute (NCI); Oregon Health and Science UniversityCompletedHematopoietic and Lymphoid Cell Neoplasm | Malignant Solid NeoplasmUnited States
-
City of Hope Medical CenterPatient-Centered Outcomes Research Institute; National Cancer Institute (NCI)Active, not recruitingMalignant Solid Neoplasm | Digestive System Carcinoma | Malignant Female Reproductive System Neoplasm | Genitourinary System CarcinomaUnited States
-
Stanford UniversityCompletedStage I Uterine Corpus Cancer AJCC v7 | Stage IA Uterine Corpus Cancer AJCC v7 | Stage IB Uterine Corpus Cancer AJCC v7 | Stage II Uterine Corpus Cancer AJCC v7 | Cancer Survivor | Endometrial Carcinoma | Stage IIIA Uterine Corpus Cancer AJCC v7United States
-
Thomas Jefferson UniversityCompletedHead and Neck Carcinoma | Lung Carcinoma | Oral Cavity Carcinoma | Paranasal Sinus Carcinoma | Stage III Laryngeal Cancer AJCC v8 | Stage IV Laryngeal Cancer AJCC v8 | Hypopharyngeal Carcinoma | Laryngeal Carcinoma | Stage IVA Laryngeal Cancer AJCC v8 | Stage IVB Laryngeal Cancer AJCC v8 | Stage IVC Laryngeal... and other conditionsUnited States
-
Emory UniversityNational Cancer Institute (NCI); National Institutes of Health (NIH); NRG OncologyCompletedAnatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage IA Breast Cancer AJCC v8 | Anatomic Stage IB Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIA Breast Cancer AJCC v8 | Anatomic Stage IIB Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Anatomic... and other conditionsUnited States
-
Centre Hospitalier Universitaire de NiceCompleted- Mild and Moderate Presbycusis (20 to 50 dB Average Hearing Loss at 500, 1000, 2000 Hz and 4000 Hz)France
-
St. Jude Children's Research HospitalRecruitingChildhood CancerUnited States
-
King Abdulaziz UniversityRecruitingObstructive Sleep ApneaSaudi Arabia